Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Is a point mutation in the mitochondrial ND2 gene associated with Alzheimer's disease.

Petruzzella V, Chen X, Schon EA.

Biochem Biophys Res Commun. 1992 Jul 15;186(1):491-7.

PMID:
1352971
2.

A comparison of single nucleotide primer extension with mispairing PCR-RFLP in detecting a point mutation.

Lin FH, Lin R.

Biochem Biophys Res Commun. 1992 Dec 15;189(2):1202-6.

PMID:
1361728
3.

Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains.

Lin FH, Lin R, Wisniewski HM, Hwang YW, Grundke-Iqbal I, Healy-Louie G, Iqbal K.

Biochem Biophys Res Commun. 1992 Jan 15;182(1):238-46.

PMID:
1370613
4.

No association of mutations at nucleotide 5460 of mitochondrial NADH dehydrogenase with Alzheimer's disease.

Kösel S, Egensperger R, Mehraein P, Graeber MB.

Biochem Biophys Res Commun. 1994 Sep 15;203(2):745-9.

PMID:
8093052
5.

The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer's brain.

Chang SW, Zhang D, Chung HD, Zassenhaus HP.

Biochem Biophys Res Commun. 2000 Jun 24;273(1):203-8.

PMID:
10873587
6.
7.

Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease.

Peacock ML, Murman DL, Sima AA, Warren JT Jr, Roses AD, Fink JK.

Ann Neurol. 1994 Apr;35(4):432-8.

8.

Investigations on the point mutations at nt 5460 of the mtDNA in different neurodegenerative and neuromuscular diseases.

Janetzky B, Schmid C, Bischof F, Frölich L, Gsell W, Kalaria RN, Riederer P, Reichmann H.

Eur Neurol. 1996;36(3):149-53.

PMID:
8738945
9.

Low mutational burden of individual acquired mitochondrial DNA mutations in brain.

Simon DK, Lin MT, Ahn CH, Liu GJ, Gibson GE, Beal MF, Johns DR.

Genomics. 2001 Apr 1;73(1):113-6.

PMID:
11352572
10.

Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA).

Brown AM, Sheu RK, Mohs R, Haroutunian V, Blass JP.

J Mol Neurosci. 2001 Feb;16(1):41-8.

PMID:
11345519
11.

Mitochondrial DNA mutations in Alzheimer's disease.

Hutchin TP, Heath PR, Pearson RC, Sinclair AJ.

Biochem Biophys Res Commun. 1997 Dec 18;241(2):221-5.

PMID:
9425253
12.

High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain.

Lin MT, Simon DK, Ahn CH, Kim LM, Beal MF.

Hum Mol Genet. 2002 Jan 15;11(2):133-45.

PMID:
11809722
13.

Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients.

Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC, Gearing M, Salvo R, et al.

Genomics. 1993 Jul;17(1):171-84.

PMID:
8104867
14.

No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant.

Wragg MA, Talbot CJ, Morris JC, Lendon CL, Goate AM.

Neurosci Lett. 1995 Dec 8;201(2):107-10.

PMID:
8848229
15.
16.
17.

Detection of low levels of the mitochondrial tRNALeu(UUR) 3243A>G mutation in blood derived from patients with diabetes.

Procaccio V, Neckelmann N, Paquis-Flucklinger V, Bannwarth S, Jimenez R, Davila A, Poole JC, Wallace DC.

Mol Diagn Ther. 2006;10(6):381-9.

PMID:
17154655
18.

[Mitochondrial DNA 3243, 3316 point mutations and type 2 diabetes mellitus].

Tang J, Li J, Tian X, Kong Q, Zhang Y.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Apr;22(2):198-200. Chinese.

PMID:
15793785
19.

Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease.

Ito S, Ohta S, Nishimaki K, Kagawa Y, Soma R, Kuno SY, Komatsuzaki Y, Mizusawa H, Hayashi J.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2099-103.

20.

Supplemental Content

Support Center